News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,672 Results
Type
Article (88848)
Company Profile (816)
Press Release (794986)
Multimedia
Podcasts (240)
Webinars (35)
Section
Business (233625)
Career Advice (4164)
Deals (40004)
Drug Delivery (179)
Drug Development (91740)
Employer Resources (207)
FDA (18566)
Job Trends (17491)
News (398801)
Policy (40018)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3055)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (208)
Alliances (56990)
ALS (241)
Alzheimer's disease (1983)
Antibody-drug conjugate (ADC) (567)
Approvals (18933)
Artificial intelligence (894)
ASCO (345)
Autoimmune disease (367)
Automation (68)
Bankruptcy (409)
Best Places to Work (12635)
BIO (69)
BIOSECURE Act (23)
Biosimilars (250)
Biotechnology (481)
Bladder cancer (213)
Brain cancer (85)
Breast cancer (846)
Cancer (6672)
Cardiovascular disease (562)
Career advice (3600)
Career pathing (52)
CAR-T (389)
CDC (77)
Celiac Disease (3)
Cell therapy (1087)
Cervical cancer (56)
Clinical research (79183)
Collaboration (2415)
Commercialization (1)
Company closure (8)
Compensation (1541)
Complete response letters (107)
COVID-19 (3043)
CRISPR (127)
C-suite (1312)
Cystic fibrosis (168)
Data (8827)
Decentralized trials (3)
Denatured (92)
Depression (199)
Dermatology (99)
Diabetes (717)
Diagnostics (7617)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (444)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (321)
Earnings (102507)
Editorial (80)
Employer branding (25)
Employer resources (175)
Events (138837)
Executive appointments (1205)
FDA (22716)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1985)
Gene editing (275)
Generative AI (91)
Gene therapy (860)
GLP-1 (1291)
Government (5565)
Grass and pollen (8)
Guidances (423)
Healthcare (21269)
Hematology (198)
HIV (99)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (360)
Immuno-oncology (116)
Indications (217)
Infectious disease (3450)
Inflammatory bowel disease (245)
Inflation Reduction Act (17)
Influenza (153)
Intellectual property (327)
Interviews (822)
IPO (18007)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (125)
Layoffs (691)
Leadership (54)
Legal (10171)
Liver cancer (111)
Longevity (38)
Lung cancer (881)
Lymphoma (483)
Machine learning (69)
Management (67)
Manufacturing (1261)
Marketing (2)
MASH (229)
Medical affairs (1)
Medical device (15291)
Medtech (15465)
Mergers & acquisitions (23315)
Metabolic disorders (1849)
mRNA (273)
Multiple sclerosis (209)
NASH (24)
Neurodegenerative disease (520)
Neuropsychiatric disorders (130)
Neuroscience (3768)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5147)
Now hiring (82)
Obesity (878)
Opinion (377)
Ovarian cancer (247)
Pain (288)
Pancreatic cancer (366)
Parkinson's disease (423)
Partnered (41)
Patents (668)
Patient recruitment (782)
Peanut (71)
People (68082)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24472)
Phase 2 (34402)
Phase 3 (25861)
Pipeline (9995)
Policy (402)
Postmarket research (3560)
Preclinical (10995)
Press Release (72)
Prostate cancer (353)
Psychedelics (73)
Radiopharmaceuticals (375)
Rare diseases (1290)
Real estate (7462)
Recruiting (81)
Regulatory (30493)
Reports (77)
Research institute (2773)
Resumes & cover letters (654)
Rett syndrome (44)
RNA editing (30)
RSV (100)
Schizophrenia (197)
Series A (340)
Series B (246)
Service/supplier (28)
Sickle cell disease (129)
Special edition (32)
Spinal muscular atrophy (191)
Sponsored (55)
Startups (4374)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (145)
Vaccines (1317)
Venture capital (140)
Weight loss (601)
Women's health (144)
Worklife (25)
Date
Today (104)
Last 7 days (482)
Last 30 days (2822)
Last 365 days (33198)
2026 (17035)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (408)
Arkansas (16)
Asia (52359)
Australia (9201)
California (14526)
Canada (4057)
China (1605)
Colorado (625)
Connecticut (647)
Delaware (450)
Europe (120740)
Florida (2170)
Georgia (471)
Hawaii (4)
Idaho (70)
Illinois (1269)
India (105)
Indiana (672)
Iowa (26)
Japan (610)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1755)
Massachusetts (10639)
Michigan (427)
Minnesota (810)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3853)
New Mexico (35)
New York (3821)
North Carolina (1952)
North Dakota (11)
Northern California (7226)
Ohio (455)
Oklahoma (27)
Oregon (55)
Pennsylvania (2853)
Puerto Rico (33)
Rhode Island (55)
South America (1668)
South Carolina (89)
South Dakota (2)
Southern California (5708)
Tennessee (233)
Texas (2375)
United States (51990)
Utah (434)
Vermont (2)
Virginia (374)
Washington D.C. (89)
Washington State (1192)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,672 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 24, 2026
·
3 min read
Business
Takeda enters transitional year as new CEO seeks return to growth
For the 2026 fiscal year, Takeda anticipates declines in revenue and profit, highlighting what CEO-elect Julie Kim says is the need for the company to “invest in future growth.”
June 24, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Nyxoah to Host Investor Day in New York on July 8, 2026
June 24, 2026
·
5 min read
China
BIO 2026: US needs to dodge China’s ‘inescapable dependencies’ to protect biotech
Speaking to media on Tuesday, BIO CEO John Crowley complimented China’s rise as a biotech powerhouse but said U.S. policy needs to protect and maintain America’s lead.
June 24, 2026
·
2 min read
·
Annalee Armstrong
Venture capital
Ollin parlays Vabysmo beat into $330M raise to test eye disease drug in Phase 3
With positive feedback on a Phase 3 trial design, Ollin Biosciences has collected a $330 million series B to advance its VEGF/Ang2 antibody, which bested Genentech’s therapy in a head-to-head study.
June 24, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
June 24, 2026
·
7 min read
Press Releases
Nicklaus Children’s performs region’s first pediatric total hip replacement using innovative mixed reality-assisted surgical guidance
June 24, 2026
·
4 min read
Press Releases
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
June 24, 2026
·
7 min read
Career Advice
The most dangerous person in the company
Controlling CEOs, manipulative middle managers and high-performing jerks can damage employees’ trust in employers and motivate them to hit the job market. Kaye/Bassman’s Michael Pietrack discusses the problematic behaviors executives must watch for in the workplace.
June 24, 2026
·
5 min read
·
Michael Pietrack
Press Releases
Novartis Canada and SP Quebec Celebrate 16 Years of Partnership Through Annual MS Tri-Challenge Fundraiser
June 24, 2026
·
4 min read
1 of 88,468
Next
